Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3679156 | 0.84 | CYP3A4 (0.33) | ACHETAAR1 | |
| SCHEMBL24004629 | 0.77 | — | — | |
| SCHEMBL18631995 | 0.77 | TAAR1 (0.31) | ACHETAAR1NFE2L2 | |
| SCHEMBL30700143 | 0.75 | ACHE (0.41) | ACHETAAR1NFE2L2IDO1L3MBTL1 | |
| SCHEMBL476837 | 0.75 | ACHE (0.41) | ACHETAAR1NFE2L2IDO1L3MBTL1 | |
| SCHEMBL5609264 | 0.73 | ACHE (0.33) | ACHEL3MBTL1LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL11570767 | 0.72 | ACHE (0.39) | ACHETAAR1NFE2L2IDO1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL11570761 | 0.72 | ACHE (0.39) | ACHETAAR1NFE2L2IDO1L3MBTL1 | |
| SCHEMBL18632029 | 0.71 | CYP3A4 (0.30) | — | |
| SCHEMBL2154282 | 0.70 | ACHE (0.38) | ACHETAAR1NFE2L2IDO1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-11-28 | — | — | US | disclosed |
| EP-3907004-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF, CATALYST COMPOSITION, AND ETHYLENE OLIGOMERIZATION, TRIMERIZATION AND TETRAMERIZATION METHODS | CHINA PETROLEUM & CHEM CORP (CN) | 2023-09-13 | — | — | EP | disclosed |
| US-20220072523-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-03-10 | — | — | US | disclosed |
| EP-3907003-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | China Petroleum & Chemical Corporation (CN) | 2021-11-10 | — | — | EP | disclosed |
| WO-2020147373-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF, CATALYST COMPOSITION, AND ETHYLENE OLIGOMERIZATION, TRIMERIZATION AND TETRAMERIZATION METHODS | 中国石油化工股份有限公司 | 2020-07-23 | — | — | WO | disclosed |
| WO-2020147372-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | 中国石油化工股份有限公司 | 2020-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220072523-A1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | C9, NOD1, ETV6 | ACHE 1257/4885TAAR1 414/4885NFE2L2 1096/4885 |
| US-11826743-B2 | Halogen-containing compound and use thereof as catalyst ligand in ethylene oligomerization | NOD1, C9, NOD2 | ACHE 1307/4885TAAR1 344/4885NFE2L2 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.